METTL3 and hepatocellular carcinoma: Therefore, our results demonstrate that, unlike its role in established HCC, METTL3 has a tumor‐inhibitory effect on the occurrence of HCC in the early stages of its development, suggesting that future liver cancer treatments targeting METTL3 should consider the stage of tumor progression.